bf/NASDAQ:CRBP_icon.jpeg

NASDAQ:CRBP

Corbus Pharmaceuticals Holdings, Inc.

  • Stock

USD

Last Close

55.45

26/07 20:00

Market Cap

550.26M

Beta: 2.42

Volume Today

226.88K

Avg: 480.30K

PE Ratio

−2.34

PFCF: −2.23

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
648.38K
-
1.91M
194.80%
2.44M
27.66%
4.82M
97.62%
36.14M
649.51%
3.94M
89.11%
881.71K
77.61%
cost of revenue
89.60K
-
98.27K
9.67%
1.64M
1,568.14%
1.49M
9.23%
641K
56.92%
gross profit
648.38K
-
1.91M
194.80%
2.44M
27.66%
4.82M
97.62%
36.05M
647.66%
3.84M
89.35%
-757.53K
119.73%
-1.49M
96.41%
-641K
56.92%
selling and marketing expenses
-13.90B
-
general and administrative expenses
346.61K
-
1.39M
301.50%
3.61M
159.65%
6.46M
78.77%
8.96M
38.77%
12.96M
44.53%
23.64M
82.49%
28.48M
20.46%
20.43M
28.28%
18.70M
8.45%
13.91B
74,288.60%
selling general and administrative expenses
346.61K
-
1.39M
301.50%
3.61M
159.65%
6.46M
78.77%
8.96M
38.77%
12.96M
44.53%
23.64M
82.49%
28.48M
20.46%
20.43M
28.28%
18.70M
8.45%
13.27M
29.04%
research and development expenses
210.67K
-
1.26M
495.97%
5.89M
369.02%
15.44M
162.14%
26.04M
68.68%
48.61M
86.70%
89.60M
84.32%
98.27M
9.67%
36.45M
62.91%
16.14M
55.72%
31.17M
93.15%
other expenses
4.58M
-
13.27M
189.63%
11.90M
10.33%
-48.77K
100.41%
cost and expenses
557.28K
-
2.65M
375.02%
9.50M
258.95%
21.90M
130.44%
35.00M
59.86%
61.57M
75.90%
113.25M
83.93%
126.75M
11.92%
56.87M
55.13%
34.84M
38.75%
45.08M
29.40%
operating expenses
557.28K
-
2.65M
375.02%
9.50M
258.95%
21.90M
130.44%
35.00M
59.86%
61.57M
75.90%
113.25M
83.93%
126.75M
11.92%
56.87M
55.13%
34.84M
38.75%
44.44M
27.56%
interest expense
45.11K
-
24.02K
46.75%
2.44K
89.84%
183.11K
-
19.02K
-
-1.03M
5,505.30%
-1.83B
177,900.68%
-2.13M
99.88%
2.92M
237.14%
ebitda
-556.52K
-
-2.63M
373.41%
-8.81M
234.25%
-19.88M
125.78%
-32.52M
63.56%
-56.84M
74.78%
-76.95M
35.37%
-122.11M
58.69%
-56.27M
53.92%
-29.50M
47.56%
-44.44M
50.61%
operating income
-557.28K
-
-2.65M
375.02%
-8.85M
234.46%
-19.99M
125.73%
-32.56M
62.94%
-56.75M
74.27%
-77.10M
35.87%
-122.81M
59.28%
-55.99M
54.41%
-39.84M
28.85%
-45.08M
13.16%
depreciation and amortization
754
-
10.40K
1,279.97%
43.94K
322.33%
87.66K
99.49%
255.65K
191.63%
493.94K
93.21%
158.62K
67.89%
701.00K
341.94%
-279.09K
139.81%
10.33M
3,801.50%
641K
93.80%
total other income expenses net
-714
-
128.59K
18,110.36%
1.98K
98.46%
-14.09K
812.90%
-41.91K
197.35%
92.79K
321.42%
5.65M
5,989.88%
11.54M
104.23%
10.35M
10.33%
-2.51M
124.27%
473.98K
118.87%
income before tax
-602.35K
-
-2.54M
321.76%
-8.85M
248.39%
-20.00M
125.95%
-32.42M
62.12%
-55.67M
71.71%
-71.45M
28.35%
-111.27M
55.72%
-45.64M
58.98%
-42.35M
7.22%
-44.60M
5.33%
income tax expense
44.36K
-
24.02K
45.85%
2.44K
89.84%
13.62K
458.07%
-396.86K
3,014.42%
1.08M
371.02%
-2.30M
313.73%
35.05K
101.52%
-87.84K
350.64%
13.49M
15,453.59%
net income
-602.35K
-
-2.54M
321.76%
-8.85M
248.39%
-20.00M
125.95%
-32.42M
62.12%
-55.67M
71.71%
-69.15M
24.22%
-111.30M
60.95%
-45.55M
59.07%
-55.83M
22.57%
-44.60M
20.11%
weighted average shs out
860.06K
-
672.00K
21.87%
1.05M
55.51%
1.37M
31.22%
1.67M
21.97%
1.90M
13.60%
2.13M
12.10%
2.60M
22.28%
4.10M
57.41%
4.17M
1.73%
4.33M
3.76%
weighted average shs out dil
860.06K
-
672.00K
21.87%
1.05M
55.51%
1.37M
31.22%
1.67M
21.97%
1.90M
13.60%
2.13M
12.10%
2.60M
22.28%
4.10M
57.41%
4.17M
1.73%
4.33M
3.76%
eps
-0.70
-
-3.78
440.00%
-8.47
124.07%
-14.58
72.14%
-19.38
32.92%
-29.30
51.19%
-32.47
10.82%
-42.74
31.63%
-11.11
74.01%
-13.39
20.52%
-10.31
23.00%
epsdiluted
-0.70
-
-3.78
440.00%
-8.47
124.07%
-14.58
72.14%
-19.38
32.92%
-29.30
51.19%
-32.47
10.82%
-42.74
31.63%
-11.11
74.01%
-13.39
20.52%
-10.31
23.00%

All numbers in USD (except ratios and percentages)